Initial report: 07/17/19

Investview has Exponential Potential

Update: 12/6/19 raises share price targets for Investview after it hires new CEO

Update: 1/5/21

Research update including price target projections and new “buy” limit price


November 13, 2019

Based on the following developments’s buy limit price for Investview is now $0.03.   The limit price had been $0.022 since August 13, 2019.

  1. Share price traded as high as $0.029 before closing at $0.023 on November 13, 2019.
  2. Share volume of 4.3 million on November 13th was almost double the total of 2.3 million of shares that traded from November 1st through 12th.
  3. INVU will be releasing results for its quarter ended September 30, 2019 on November 14th.
  4. Based on INVU’s October 4, 2019 press release is projecting that for the company will have quarterly revenue of above $10 million for the first time ever and also positive cash flow for its second consecutive quarter. 

August 24, 2019

Investview reporting its first ever quarter of positive operating cash flow for its quarter ended June 30, 2019 was a monumental achievement.  Company has a model and share price very similar to my finding Investools in 2003 at under $1.00.   Investools was acquired by Ameritrade for over $10 per share in 2008.   Home page video provides details about algorithm that was utilized to find Investools.

August 13, 2019

Share price buy limit raised to $0.022.  Daily trading volume since August 5th at a fraction of the 1.8 million shares per day which were sold from August 1st to 5th.   Selling has been exhausted at below $0.02.

August 7, 2019

Annette Raynor being appointed as CEO is a very positive development.  Since I am the startups expert/consultant for Investview’s Kuvera subsidiary I am very familiar with Annette.  She is intelligent, bright and has vast experience with technology and especially knowledgeable about big data.   By the way, I receive $2500 per month from Kuvera and I do not have any shares or options in Kuvera or Investview.

July 28, 2019

The share price has been under pressure since initial recommendation due to the institution who sold millions of shares in June now selling again.   New limit price is $0.015 which is below recommended price.  High since July 17, 2019, $0.021.